Results 291 to 300 of about 189,117 (342)

Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET). [PDF]

Am J Epidemiol
Baptiste PJ, Wong AYS, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JFE, Cunnington M, Teo K, Bangdiwala SI, Gao P, Tomlinson L, Wing K.   +13 more
europepmc   +1 more source

The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors. [PDF]

Iran J Med Sci
Abd-El-Fatah SS, Fathy MA, Alabiad MA, Aljafil R, Gobran MA, Ahmad EA, Alsharidah AS, Alorini M, Alnasser SM, Awadh SA, Morgan EN.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Angiotensin-Converting Enzyme Inhibitors

Medical Clinics of North America, 1988
There is convincing evidence that ACE inhibitors, alone or in combination with a diuretic, effectively lower blood pressure in patients with all grades of essential or renovascular hypertension and that they are of particular benefit as adjunctive therapy in patients with congestive heart failure.
H H, Rotmensch, P H, Vlasses, R K, Ferguson   +2 more
  +7 more sources

[Angiotensin-converting enzyme inhibitors].

Recenti progressi in medicina, 1991
The introduction of angiotensin-converting enzyme (ACE) inhibitors for the treatment of hypertension and heart failure is probably the most important advance in cardiovascular pharmacotherapy in the last few decades. Although the role of the renin-angiotensin system (RAS) in cardiovascular diseases had been investigated extensively for more than 70 yr,
Irene Gavras, Haralambos Gavras
openaire   +4 more sources

Angiotensin Converting Enzyme Inhibitors

American Journal of Hypertension, 1990
This review focuses on the use of angiotensin converting enzyme (ACE) inhibitors in hypertensive diseases. Specifically discussed are: proposed mechanisms of action, the pharmacology of the commercially available ACE inhibitors (captopril, enalapril, and lisinopril), their renal effects, and their safety and efficacy.
B L, Herlihy, J T, Herlihy
openaire   +4 more sources

Angiotensin-Converting Enzyme Inhibitor Angioedema

Advanced Emergency Nursing Journal, 2020
Angioedema from angiotensin-converting enzyme inhibitors (ACEIs) is a potential, emergent, and frightening problem that presents to the emergency department. This article focuses on angioedema caused by using ACEIs. The presentation, pathology, diagnostic testing, treatment, and patient education of angioedema are explored.
Josh, Bankston, David Thomas, House
openaire   +4 more sources

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1994
Over many decades, the role of renin-angrotensin system in cardiovascular disorders has been redefined and expanded. Strongly interwoven with this process has been the development of pharmacologic probes that have helped to define this role.
  +7 more sources

Angiotensin-converting enzyme inhibitors

2001
Publisher Summary Angiotensin-converting enzyme (ACE) inhibitors were first studied clinically in the 1970s. ACE inhibitors were discovered by taking advantage of previous basic research on the physiology of sodium, potassium, and water homeostasis and blood pressure regulation, in a reciprocal way ACE have also advanced research in this field, and ...
J, Menard, A A, Patchett
openaire   +3 more sources